|
Net loss per share is computed using
the weighted average number of shares of Common Stock outstanding less the number of shares subject to repurchase.
The following table sets forth the
computation of basic and diluted net loss per share for the periods indicated (in thousands, except share data):
| Schedule of basic and diluted net loss per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Three Months Ended September 30,
|
|
|
Nine Months Ended September 30,
|
|
| |
|
2021 |
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
| Numerator: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net loss |
|
$ |
(26,953 |
) |
|
$ |
(9,921 |
) |
|
$ |
(50,920 |
) |
|
$ |
(33,989 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Denominator - basic and diluted: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Weighted average common shares outstanding |
|
|
66,276,223 |
|
|
|
59,710,047 |
|
|
|
61,923,661 |
|
|
|
59,710,047 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net loss per share - basic and diluted |
|
$ |
(0.41 |
) |
|
$ |
(0.17 |
) |
|
$ |
(0.82 |
) |
|
$ |
(0.57 |
) |
The following table sets forth the
amounts excluded from the computation of diluted net loss per share as of September 30, 2021 and 2020 because their effect was anti-dilutive.
| Schedule of anti-dilutive net loss per share |
|
|
|
|
|
|
|
|
| |
|
September 30, |
|
| |
|
2021 |
|
|
2020 |
|
| Stock options outstanding |
|
|
5,773,428 |
|
|
|
5,557,254 |
|
| Non-vested shares of restricted stock |
|
|
345,471 |
|
|
|
345,817 |
|
| Warrants (a) |
|
|
|
|
|
|
|
|
| Convertible notes (a) |
|
|
|
|
|
|
|
|
|
(a) |
The Convertible Notes and warrants referred to in Notes 10 and 14 were also excluded on an as converted
basis because their effect would have been anti-dilutive. |
|